Rational development of high-affinity T-cell receptor-like antibodies (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 14, (5784-5788) DOI: 10.1073/pnas.0901425106);Rational development of high-affinity T-cell receptor-like antibodies

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 14, 2009, Pages 5784-5788

  Stewart Jones, Guillaume ^a,b   Wadle, Andreas ^c   Hombach, Anja ^d   Shenderov, Eugene ^b,e   Held, Gerhard ^f   Fischer, Eliane ^c   Kleber, Sascha ^c   Stenner Liewen, Frank ^c   Bauer, Stefan ^c   McMichael, Andrew ^b   Knuth, Alexander ^c   Abken, Hinrich ^d   Hombach, Andreas A ^d   Cerundolo, Vincenzo ^b   Jones, E Yvonne ^a   Renner, Christoph ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF COLOGNE   (Germany)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f SAARLAND UNIVERSITY   (Germany)

Author keywords

Antibody engineering; Crystallography; Tumor immunology

Indexed keywords

ANTIBODY; HLA A11 ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; METHIONINE; T LYMPHOCYTE RECEPTOR; TRYPTOPHAN;

ANTIBODY LIBRARY; ARTICLE; CELL INTERACTION; CELL MATURATION; CRYSTAL STRUCTURE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN BINDING;

ANTIBODIES; ANTIBODY AFFINITY; CRYSTALLOGRAPHY, X-RAY; CYTOTOXICITY, IMMUNOLOGIC; HLA-A ANTIGENS; IMMUNOGLOBULIN FAB FRAGMENTS; MOLECULAR MIMICRY; PEPTIDE LIBRARY; PROTEIN ENGINEERING; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 65249176824     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905399106     Document Type: Erratum

References (31)

1. Mak TW (2007) The T cell antigen receptor: ''The Hunting of the Snark.'' Eur J Immunol 37(Suppl 1):S83-S93.
2. Chames P, Hufton SE, Coulie PG, Uchanska-Ziegler B, Hoogenboom HR (2000) Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA- A1-MAGE-A1 from a nonimmunized phage-Fab library. Proc Natl Acad Sci USA 97(14):7969-7974.
3. Konig R (2002) Interactions between MHC molecules and co-receptors of the TCR. Curr Opin Immunol 14(1)75-83.
4. Zhao Y, etal. (2007) High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol 179(9):5845-5854.
5. Holler PD, Chlewicki LK, Kranz DM (2003) TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol 4(1):55-62.
6. Weber KS, Donermeyer DL, Allen PM, Kranz DM (2005) Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc Natl Acad Sci USA 102(52):19033-19038.
7. Colf LA, etal. (2007) How a single T cell receptor recognizes both self and foreign MHC. Cell 129(1):135-146.
8. Chen JL, etal. (2005) Structural and kinetic basis for heightened immunogenicityof Tcell vaccines. J Exp Med 201(8):1243-1255.
9. Li Y, etal. (2005) Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol 23(3):349-354.
10. Greenspan NS (2001) Affinity, complementarity, cooperativity, and specificity in antibody recognition. Curr Top Microbiol Immunol 260:65-85.
11. Denkberg G, ReiterY (2006) Recombinant antibodies with T-cell receptor-like specificity: Novel tools to study MHC class I presentation. Autoimmun Rev 5(4):252-257.
12. Hulsmeyer M, et al. (2005) A major histocompatibility complex-peptide-restricted antibody and T cell receptor molecules recognize their target by distinct binding modes: Crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB- HYB3. J Biol Chem 280(4):2972-2980.
13. Willemsen RA, Ronteltap C, ChamesP, Debets R, Bolhuis RL (2005) Tcell retargeting with MHC class I-restricted antibodies: The CD28 costimulatory domain enhances antigenspecific cytotoxicity and cytokine production. J Immunol 174(12)7853-7858.
14. Held G, etal. (2004) Dissecting cytotoxic Tcell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments. Eur J Immunol 34(10):2919-2929.
15. Lee JK, etal. (2004) Tcell cross-reactivity and conformational changes during TCR engagement. J Exp Med 200(11):1455-1466.
16. Tynan FE, etal. (2005) Tcell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol 6(11):1114-1122.
17. Li Y, Li H, Yang F, Smith-Gill SJ, Mariuzza RA (2003) X-ray snapshots of the maturation of an antibody response to a protein antigen. Nat Struct Biol 10(6):482-488.
18. Hombach A, et al. (2001) Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule. J Immunol 167(11):6123-6131.
19. Ishizuka J, et al. (2008) The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity 28(2):171-182.
20. Tynan FE, et al. (2005) High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem 280(25):23900-23909.
21. Hoet RM, et al. (2005) Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat Biotechnol 23(3):344-348.
22. Derre L, et al. (2008) Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues. Proc Natl Acad Sci USA 105(39):15010-15015.
23. Robbins PF, et al. (2008) Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J Immunol 180(9):6116-6131.
24. Chen YT, Old LJ (1999) Cancer-testis antigens: Targets for cancer immunotherapy. Cancer J Sci Am 5(1):16-17.
25. Chen YT, et al. (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94(5):1914-1918.
26. Walter TS, et al. (2005) A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr D Biol Crystallogr 61(Pt 6):651-657.
27. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ (2005) Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61(Pt 4):458-464.
28. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53(Pt 3):240-255.
29. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1):2126-2132.
30. Morris RJ, Perrakis A, Lamzin VS (2003) ARP/wARP and automatic interpretation of protein electron density maps. Methods Enzymol 374:229-244.
31. Potterton L, et al. (2004) Developments in the CCP4 molecular-graphics project. Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1):2288-2294.